31 Mar 2022
Assets6,063.47
Total Income5,918.86
Profit After Tax702.56
NET Worth1,987.55
Reserves and Surplus1,791.03
Total Borrowing2,102.19
At a glance
Updated 2026-08-24Emcure Pharma is a Mainboard IPO with an issue size of ₹1,952.03 crore, proposed for listing on BSE, NSE. The issue structure includes a fresh issue of ₹800.58 crore and an offer-for-sale component of ₹1,151.45 crore.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹1,952.03 Cr
Fresh issue₹800.58 Cr
Offer for sale₹1,151.45 Cr
Face value₹10
Price band₹960.00–₹1,008.00
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Use of proceeds
| Object | Amount |
|---|---|
| Repayment and/or prepayment of all or a portion of certain outstanding borrowings availed by our Company | ₹800.00 Cr |
| General corporate purposes | ₹41.14 Cr |
Financials
Full financials ↗31 Mar 2023
Assets6,672.53
Total Income6,031.72
Profit After Tax561.85
NET Worth2,501.13
Reserves and Surplus2,293.77
Total Borrowing2,202.42
31 Mar 2024
Assets7,806.16
Total Income6,715.24
Profit After Tax527.58
NET Worth2,952.28
Reserves and Surplus2,722.40
Total Borrowing2,091.94
Trend chart₹ crore
KPIs
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Price to Book Value |
Valuation & shareholding
Pre-IPO EPS29.17
Post-IPO EPS27.95
Pre-IPO P/E34.55
Post-IPO P/E36.07
Promoter holding pre83.21%
Promoter holding post78.08%
Market cap₹19029.89 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| BRLMs fees and commissions (including underwriting commission, brokerage and selling commission) | ₹51.15 Cr |
| Commission/ processing fees for SCBs, Sponsor Banks, Bankers to the Offer, brokerage, selling commission, bidding charges for the Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹7.20 Cr |
| Fee payable to the Registrar to the Offer | ₹0.80 Cr |
| Listing fees, SEBI filing fees, BSE & NSE processing fees, book building software fees, NSDL and CDSL fee and other regulatory expenses, | ₹10.20 Cr |
| Printing and stationery expenses | ₹1.57 Cr |
| Fees payable to the Statutory Auditor, Independent Chartered Accountant, industry service provider, IPR consultant, independent chartered engineer and ROC consultant | ₹7.90 Cr |
| Advertising and marketing expenses for the Offer | ₹8.41 Cr |
| Fees payable to the legal counsel | ₹8.11 Cr |
| Miscellaneous | ₹4.95 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- Kotak Mahindra Capital Co.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.